pqq cofactor has been researched along with Parkinson Disease, Secondary in 2 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, Q | 1 |
Chen, J | 1 |
Guo, H | 1 |
Lu, JL | 1 |
Zhou, J | 1 |
Guo, XY | 1 |
Shi, Y | 1 |
Zhang, Y | 2 |
Yu, S | 2 |
Zhang, Q | 2 |
Ding, F | 2 |
Qin, J | 1 |
Wu, M | 1 |
Gao, X | 1 |
Zhang, J | 1 |
Dong, X | 1 |
Ji, J | 1 |
Zhou, L | 1 |
2 other studies available for pqq cofactor and Parkinson Disease, Secondary
Article | Year |
---|---|
Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson's disease model via AMPK activation.
Topics: AMP-Activated Protein Kinases; Animals; Behavior, Animal; Cell Line, Tumor; Humans; Locomotion; Male | 2021 |
Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Gene Expression Regulation; Glutathione; Humans; Ma | 2015 |